Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Cingulate Inc News
Page 10 - Cingulate Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cingulate Inc. Real-time updates on events, politics, business and more.
Cingulate and ADHD Expert Dr. Ann Childress, MD to
KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...
Source: globenewswire.com
Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
02.06.2022 - KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline ...
Source: wallstreet-online.de
Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Cingulate Inc. Reports First Quarter 2022 Results and Provides Clinical and Business Update
Announcement of First Dosage for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ Platform KANSAS CITY, Kan., May 12, 2022 -- Cingulate Inc. , a... | May 12, 2022
Source: marketscreener.com
Cingulate Presents at NobleCon18
26.04.2022 - KANSAS CITY, Kan., April 26, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a ...
Thomas Dalton Melyssa Weible Noble Capital Markets Inc Elixir Health Public Relations Cingulate Inc Precision Timed Release
Source: wallstreet-online.de
Cingulate (NASDAQ:CING) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Cingulate (NASDAQ:CING – Get Rating) released its quarterly earnings data on Thursday. The company reported ($0.32) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.07, MarketWatch Earnings reports. Shares of CING remained flat at $$1.19 during midday trading on Friday. 17,376 shares of the stock traded hands, compared to its average volume […]
United States Exchange Commission Cingulate Inc Susquehanna International Group Get Rating Marketwatch Earnings
Source: etfdailynews.com
Cingulate to Present at Aegis Virtual Conference
Cingulate to Present at Aegis Virtual Conference - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Cingulate Appoints Curt Medeiros and Gregg Givens to Board of Directors
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Aegis Capital Corp. acted as Lead Bookrunning Manager on a $25 Million Initial Public Offering of Common Stock for Cingulate Inc. (NASDAQ: CING)
NEW YORK, NY / ACCESSWIRE / December 10, 2021 / Aegis Capital Corp. acted as Lead Bookrunning Manager on a $25 Million Initial Public Offering of Common Stock for Cingulate Inc. (NASDAQ:CING).Cingulate
Investment Banking Services Aegis Capital Corporation Cingulate Inc Aegis Capital Corp Aegis Capital Lead Bookrunning Manager
Source: finanznachrichten.de